|
2024
|
Invention
|
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders. ... |
|
2023
|
Invention
|
Macrocyclic compounds for treatment of medical disorders.
Macrocyclic Complement Factor D inhibi... |
|
|
Invention
|
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders. C... |
|
|
Invention
|
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders. Compounds, metho... |
|
2022
|
Invention
|
Pharmaceutical compounds for treatment of medical disorders. Complement Factor D inhibitors, phar... |
|
2021
|
Invention
|
Quinazoline and indole compounds to treat medical disorders.
Compounds, methods of use, and proc... |
|
|
Invention
|
Pharmaceutical compounds for the treatment of complement mediated disorders. This disclosure prov... |
|
|
Invention
|
Macrocyclic compounds for treatment of medical disorders. Macrocyclic Complement Factor D inhibit... |
|
|
Invention
|
Ocular drug depot for complement-mediated disorders.
This disclosure provides an ocular tissue d... |
|
|
Invention
|
Ocular drug depot for complement-mediated disorders. This disclosure provides an ocular tissue de... |
|
|
Invention
|
Heteroaryl compounds for treatment of complement factor d mediated disorders. Compounds, methods ... |
|
2020
|
Invention
|
Amino compounds for treatment of immune and inflammatory disorders. Compounds, methods of use, an... |
|
|
Invention
|
Amide compounds for treatment of immune and inflammatory disorders. Compounds, methods of use, an... |
|
|
Invention
|
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders.
Compounds, meth... |
|
|
Invention
|
Pharmaceutical compounds for the treatment of complement mediated disorders.
This disclosure pro... |
|
|
Invention
|
Quinazoline and indole compounds to treat medical disorders. Compounds, methods of use, and proce... |
|
2019
|
Invention
|
Targeted dosing for the treatment of complement mediated disorders.
The dosages and methods desc... |
|
|
Invention
|
Targeted dosing for the treatment of complement mediated disorders. The dosages and methods descr... |
|
|
Invention
|
Targeted dosing for the treatment of complement mediated disorders. troughmaxmax, providing addit... |
|
|
Invention
|
Therapeutic regimens for treatment of paroxysmal nocturnal hemoglobinuria. Provided herein are me... |
|
|
Invention
|
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders. 32) ... |
|
|
Invention
|
Morphic forms of complement factor d inhibitors. This invention provides stable, highly crystalli... |
|
|
Invention
|
Morphic forms of danicopan. This invention provides stable, highly crystalline forms of Complemen... |
|
|
Invention
|
Macrocyclic compounds for the treatment of medical disorders. Compounds, methods of use, and proc... |
|
|
Invention
|
Morphic forms of dancopan. This invention provides stable, highly crystalline forms of Complement... |
|
|
Invention
|
Pharmaceutical compounds for the treatment of complement factor d medical disorders.
Compounds, ... |
|
|
Invention
|
Pharmaceutical compounds for the treatment of complement factor d medical disorders. Compounds, m... |
|
|
Invention
|
Complement alternative pathway-associated nephropathy biomarkers.
Provided herein are methods fo... |
|
|
Invention
|
Complement alternative pathway-associated nephropathy biomarkers. Provided herein are methods for... |
|
|
Invention
|
Amino compounds for treatment of complement mediated disorders. 32) are provided. The inhibitors ... |
|
2018
|
Invention
|
Ether compounds for treatment of complement mediated disorders. 32) are provided. The inhibitors ... |
|
|
Invention
|
Phosphonate compounds for treatment of complement mediated disorders. 32) are provided. The inhib... |
|
|
Invention
|
Compounds for treatment of complement mediated disorders. Compounds, methods of use, and processe... |
|
|
Invention
|
Therapeutic regimens for treatment of paroxysmal nocturnal hemoglobinuria.
Provided herein are m... |
|
|
G/S
|
Educational services, namely, providing medical information about the treatment of kidney disease... |
|
|
G/S
|
Educational services, namely, providing information about
the treatment of kidney disease (term ... |
|
2017
|
G/S
|
Pharmaceutical preparations for the treatment of immunomodulatory diseases, conditions and disord... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
immunomodulatory diseases, conditions and disor... |
|
2008
|
G/S
|
Pharmaceutical preparations for the treatment of infectious diseases, namely, hepatitis, acquired... |
|
2001
|
G/S
|
Pharmaceutical preparation for use in treating infections, viruses and diseases. |
